Military Press Releases
SEE OTHER BRANDS

The best the military industry news from the world

Military Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Military Press Releases.

Press releases published on September 22, 2025

The Enduring Fight on Cyber Warfare Sees Canada’s Former Top General Rick Hillier Side with CYPFER to Lead the Attack
A Sound Like Thunder Reimagines a Forgotten South and a Love That Defied Nations
Oculis Announces Presentation of Phase 2 ACUITY trial results with Privosegtor in Acute Optic Neuritis at ECTRIMS
Mutuum Finance (MUTM) Approaches Next Phase With 14.3% Price Increase After Raising $16 Million
BetaGlue Therapeutics Announces the Appointment of Alexis Peyroles as New Chief Executive Officer
Opening Ceremony of the 12th China Jiaozuo International Taijiquan Competition and the 2025 Yuntai Mountain Tourism Festival Held in Jiaozuo City, Henan Province
The 20th China International Mountain Outdoor Sports Open kicks off in Wulong in China's "mountain city" Chongqing
ADC Innovator Myricx Bio Appoints Boston-based Mohit Rawat as CEO and Expands Team in US and UK
vivenu führt Zweitmarkt für Tickets ein
vivenu Introduces Native Resell Platform for Tickets
vivenu lance son Marché Secondaire pour les billets
Trace One Appoints Séverine Tourpin as Chief Executive Officer
Golar LNG Limited Announces Fixed Income Investor Meetings
LEADING EDGE MATERIALS PROVIDES AN UPDATE ON THE NORR KARR HREE PROJECT
Two International Proxy Advisory Firms Support the Governance Project Proposed by OSE Immunotherapeutics at the  September 30th General Meeting
Opterion Health AG reicht Antrag auf klinische Studie für die erste Anwendung von OPT101 bei Patienten mit fortgeschrittener chronischer Nierenerkrankung ein
Deux agences internationales de conseil en vote soutiennent le projet de gouvernance proposé par OSE Immunotherapeutics à l’Assemblée Générale du 30 septembre
DTEK subsidiary, DRI, picks Fluence to deliver Trzebinia battery project
Ipsen’s LANTIC Phase II in aesthetics delivers a first-in-class, differentiated long-acting clinical profile for IPN10200, enabling the initiation of Phase III
L’essai de Phase II LANTIC d’Ipsen en esthétique démontre un profil clinique différencié à longue durée d'action, premier de sa classe pour l'IPN10200, permettant le lancement de l’étude de Phase III

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions